Abstract
Abstract The benchmark dose (BMD) methodology is a statistical procedure, first proposed by Crump in 1984, to determine allowable daily intakes of chemicals. The BMD was proposed as an alternative to the no‐observed‐adverse‐effect‐level (NOAEL) approach. The procedure is now widely used in risk assessment to establish health standards and guidelines for exposure of toxins to humans or to the environment. In this article, we review the BMD procedure, give details on how to compute the BMD and BMDL for both quantal and continuous endpoints and survey some of the recent developments in benchmark dose estimation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
